Ratings by Citi (Mohit Bansal)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/2/2021 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2021 | Sensei Biotherapeutics | SNSE | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2021 | Biogen | BIIB | Upgrade | Neutral (Sell) |
395.85 (194.38) |
-50.9% | Details | |
| 5/13/2021 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
| 5/7/2021 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | Pliant Therapeutics | PLRX | New Coverage | Buy (N/A) |
35.90 (12.52) |
-65.13% | Details | |
| 3/26/2021 | Forte Biosciences Inc. | FBRX | New Coverage | Buy (N/A) |
28.92 (0.73) |
-97.48% | Details | |
| 3/1/2021 | Sensei Biotherapeutics | SNSE | New Coverage | Buy (N/A) |
16.50 (0.97) |
-94.12% | Details | |
| 2/26/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2021 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2021 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
25.96 (10.25) |
-60.52% | Details | |
| 1/20/2021 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2021 | Regeneron Pharma | REGN | Upgrade | Buy (Neutral) |
481.20 (896.82) |
86.37% | Details | |
| 1/7/2021 | Radius Health | RDUS | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
| 12/23/2020 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Alexion Pharmaceuticals | ALXN | Downgrade | Neutral (Buy) |
120.98 (182.01) |
50.45% | Details | |
| 12/10/2020 | Amicus Therapeutics | FOLD | Downgrade | Neutral (Buy) |
22.63 (10.61) |
-53.12% | Details | |
| 11/3/2020 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
26.87 (9.58) |
-64.35% | Details | |
| 10/6/2020 | MyoKardia | MYOK | Downgrade | Neutral (Buy) |
139.60 (224.91) |
61.11% | Details | |
| 9/15/2020 | CytomX Therapeutics | CTMX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/20/2020 | BioMarin Pharmaceutical Inc. | BMRN | Downgrade | Neutral (Buy) |
118.54 (88.63) |
-25.23% | Details | |
| 8/11/2020 | Radius Health | RDUS | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
| 6/1/2020 | CytomX Therapeutics | CTMX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/12/2020 | MyoKardia | MYOK | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2020 | Regeneron Pharma | REGN | Downgrade | Neutral (Buy) |
566.21 (896.82) |
58.39% | Details | |
| 4/27/2020 | Adaptimmune Therapeutics plc | ADAP | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2020 | Biogen | BIIB | Downgrade | Sell (Neutral) |
329.01 (194.38) |
-40.92% | Details | |
| 3/27/2020 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2020 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2020 | Myovant Sciences Ltd. | MYOV | New Coverage | Neutral (N/A) |
12.76 (26.98) |
111.44% | Details | |
| 1/22/2020 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2019 | MyoKardia | MYOK | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | Radius Health | RDUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | Audentes Therapeutics | BOLD | Upgrade | Neutral (Sell) |
29.03 (10.09) |
-65.24% | Details | |
| 11/18/2019 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2019 | CytomX Therapeutics | CTMX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2019 | Regeneron Pharma | REGN | Upgrade | Buy (Neutral) |
332.60 (896.82) |
169.64% | Details | |
| 10/30/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2019 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2019 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2019 | Tocagen Inc. | TOCA | Downgrade | Neutral (Buy) |
0.93 (1.26) |
35.48% | Details | |
| 8/30/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2019 | Radius Health | RDUS | Upgrade | Buy (Neutral) |
24.34 (18.41) |
-24.36% | Details | |
| 8/9/2019 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2019 | Calithera Biosciences | CALA | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2019 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
19.69 (329.83) |
1575.11% | Details | |
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Buy (N/A) |
17.20 (24.10) |
40.12% | Details | |
| 5/30/2019 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2019 | Tocagen Inc. | TOCA | New Coverage | Buy (N/A) |
4.32 (0.93) |
-78.47% | Details | |
| 5/30/2019 | Radius Health | RDUS | New Coverage | Neutral (N/A) |
21.23 (24.34) |
14.65% | Details | |
| 5/30/2019 | Myovant Sciences Ltd. | MYOV | New Coverage | Buy (N/A) |
11.90 (12.76) |
7.23% | Details | |
| 5/30/2019 | Epizyme | EPZM | New Coverage | Buy (N/A) |
13.38 (1.47) |
-89.01% | Details | |
| 5/30/2019 | Calithera Biosciences | CALA | New Coverage | Buy (N/A) |
5.51 (0.37) |
-93.28% | Details | |
| 5/30/2019 | Adaptimmune Therapeutics plc | ADAP | New Coverage | Buy (N/A) |
3.52 (0.98) |
-72.16% | Details | |
| 5/23/2019 | Vertex | VRTX | New Coverage | Buy (N/A) |
169.12 (394.28) |
133.14% | Details | |
| 5/23/2019 | Regeneron Pharma | REGN | New Coverage | Neutral (N/A) |
309.95 (332.60) |
7.31% | Details | |
| 5/23/2019 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Buy (N/A) |
87.47 (88.63) |
1.33% | Details | |
| 5/23/2019 | Biogen | BIIB | New Coverage | Neutral (N/A) |
232.92 (194.38) |
-16.55% | Details | |
| 5/23/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Buy (N/A) |
128.80 (182.01) |
41.31% | Details | |
| 4/26/2019 | Audentes Therapeutics | BOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/26/2019 | Audentes Therapeutics | BOLD | Downgrade | Sell (Neutral) |
40.56 (10.09) |
-75.12% | Details | |
| 2/27/2019 | CytomX Therapeutics | CTMX | Downgrade | Neutral (Buy) |
19.16 (1.67) |
-91.28% | Details | |
| 1/16/2019 | Amicus Therapeutics | FOLD | Upgrade | Buy (Neutral) |
11.99 (10.61) |
-11.51% | Details | |
| 10/29/2018 | Amicus Therapeutics | FOLD | New Coverage | Neutral (N/A) |
10.96 (11.99) |
9.4% | Details | |
| 9/28/2018 | MyoKardia | MYOK | New Coverage | Buy (N/A) |
65.05 (224.91) |
245.75% | Details | |
| 8/21/2018 | Audentes Therapeutics | BOLD | New Coverage | Neutral (N/A) |
33.04 (40.56) |
22.76% | Details |
